UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038679
Receipt number R000044088
Scientific Title Clinical performance study of gene mutation test
Date of disclosure of the study information 2019/11/25
Last modified on 2021/02/15 14:44:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A feasibility study of performance of a novel method for gene mutations in circulating tumor DNA

Acronym

Clinical performance of a novel method for gene mutations in circulating tumor DNA

Scientific Title

Clinical performance study of gene mutation test

Scientific Title:Acronym

Clinical performance study of gene mutation test

Region

Japan


Condition

Condition

non-small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Feasibility verification of EGFR T790M mutation detection using the Digital ICA system, a microfluidic device

Basic objectives2

Others

Basic objectives -Others

Feasibility verification of EGFR T790M mutation detection using the Digital ICA system, a microfluidic device

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

quantification of mutant allele and minimum detection limit

Key secondary outcomes

1) Calculation of backgroud noise
2) Seach for cut-off value


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Cell free DNA samples collected in WJOG8014LTR study
2) Residual samples with informed consent that are stocked in WJOG-BBC (Bio-bank Center, West Japan Oncology Group,)
3) Ten samples (20 ng or more DNA) with EGFR T790M positive and other ten samples with EGFR T790M negative detected by the QX100 Droplet Digital PCR system (ddPCR)

Key exclusion criteria

none

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kazuto
Middle name
Last name Nishio

Organization

Kindai University Faculty of Medicine

Division name

Department of Genome Biology

Zip code

589-8511

Address

377-2 Ohno-higashi, Osaka-sayama

TEL

81-72-366-0221

Email

knishio@med.kindai.ac.jp


Public contact

Name of contact person

1st name Kazuko
Middle name
Last name Sakai

Organization

Kindai University Faculty of Medicine

Division name

Department of Genome Biology

Zip code

589-8511

Address

377-2 Ohno-higashi, Osaka-sayama

TEL

81-72-366-0221

Homepage URL


Email

kasakai@med.kindai.ac.jp


Sponsor or person

Institute

West Japan Oncology Group

Institute

Department

Personal name



Funding Source

Organization

Toppan Printing Co., Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, Kindai University Faculty of Medicine

Address

377-2 Ohno-higashi, Osaka-sayama

Tel

81-72-366-0221

Email

zizen@med.kindai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 11 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 11 Month 17 Day

Date of IRB

2019 Year 01 Month 28 Day

Anticipated trial start date

2019 Year 01 Month 28 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2019 Year 11 Month 25 Day

Last modified on

2021 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044088


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name